scPharmaceuticals Inc. Patent Listing

The following scPharmaceuticals, Inc. products are protected by patents in the U.S. and elsewhere. This website is provided to satisfy the virtual patent marking provisions set forth in 35 U.S.C. § 287. Additional patents may be granted or pending in the United States and in other countries.

 

FUROSCIX®: This product, or its use, may be covered by one or more U.S. Patents, including U.S. Patent Nos. 9,884,039; 10,272,064; and 11,433,044.

 

Date: September 12, 2022

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.